Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Inotiv Inc.

Start price
Target price
Perf. (%)
€13.40
01.05.22
-
01.05.23
-63.13%
24.04.23

Probably not worthwhile Investment
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.52
28.04.22
-
28.04.23
-2.36%
30.04.22

Risky Investment
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.37
28.04.22
€2.00
28.04.23
0.74%
03.08.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Teladoc Health Inc

Start price
Target price
Perf. (%)
€30.77
28.04.22
€25.00
28.04.23
19.70%
03.05.22

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€174.42
27.04.22
€190.00
27.04.23
-15.38%
27.04.23

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
buy
Eckert & Ziegler Strahlen- und Medizintechnik AG

Start price
Target price
Perf. (%)
€48.92
25.04.22
€120.00
03.02.25
-9.22%
16.08.24

Higher EBIT margin than peer group
Revenue growth >5% per year expected
EBIT growth >5% per year expected
High valuation
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€233.45
25.04.22
€250.00
25.04.23
14.61%
26.04.23

Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€8.69
22.04.22
-
22.04.23
3.54%
30.04.22

Could be worthwhile Investment >10% per year
buy
CEL-SCI Corp.

Start price
Target price
Perf. (%)
€2.91
21.04.22
-
21.04.23
-4.78%
01.05.22

Risky Investment
buy
Voyager Therapeutics Inc

Start price
Target price
Perf. (%)
€6.60
21.04.22
-
21.04.23
4.15%
01.05.22

Risky Investment
buy
Nektar Therapeutics

Start price
Target price
Perf. (%)
€4.42
19.04.22
-
19.04.23
-2.94%
02.05.22

Could be worthwhile Investment >10% per year
buy
Newegg Commerce Inc.

Start price
Target price
Perf. (%)
€5.95
19.04.22
€11.00
19.04.23
0.00%
02.05.22

Could be very worthwhile Investment >20% year
buy
Curis Inc.

Start price
Target price
Perf. (%)
€1.14
19.04.22
-
19.04.23
-21.19%
01.05.22

Risky Investment
buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€5.99
19.04.22
-
12.04.24
-68.19%
12.04.24

Could be worthwhile Investment >10% per year
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€5.70
18.04.22
-
18.04.23
-3.95%
30.04.22

Could be very worthwhile Investment >20% year
Inovio Pharma

Start price
Target price
Perf. (%)
€3.05
12.04.22
€1.60
12.04.23
-30.60%
03.08.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€9.86
12.04.22
-
12.04.23
-0.02%
16.04.22

Could be worthwhile Investment >10% per year
buy
Corcept Therapeutics Inc.

Start price
Target price
Perf. (%)
€21.85
12.04.22
-
12.04.23
-9.84%
12.04.23

buy
Acadia Pharmaceuticals

Start price
Target price
Perf. (%)
€21.86
12.04.22
-
12.04.23
-23.60%
12.04.23

Novavax Inc.

Start price
Target price
Perf. (%)
€52.93
11.04.22
€40.00
11.04.23
4.10%
03.05.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Affimed N.V.

Start price
Target price
Perf. (%)
€4.75
11.04.22
-
11.04.23
-41.07%
08.06.22

Could be worthwhile Investment >10% per year
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€3.16
09.04.22
-
09.04.23
0.00%
18.04.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€50.65
07.04.22
€56.00
07.04.23
-24.58%
08.04.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€15.54
07.04.22
-
07.04.23
-9.24%
18.04.22

Risky Investment
buy
Gensight Biologics SA

Start price
Target price
Perf. (%)
€2.34
07.04.22
-
07.04.23
-1.02%
08.04.23

Could be worthwhile Investment >10% per year